You recently searched for

new medicines

Skin conditions

                https://www.bootspharmacyschool.co.uk/login

Follow Topic

Bookmark

Copy Link

Nemolizumab approved for prurigo nodularis and atopic dermatitis

Nemolizumab (Nemluvio, Galderma) has been approved by the MHRA for the treatment of two skins conditions.

18 Feb 2025 , 1 Min Article

Boots Pharmacy School provides a range of high quality educational e-learning modules, videos and articles, including The Tutor Programme to support the ongoing learning of Boots pharmacy teams. It is part of The Pharmacy Network, a learning system developed and operated by Communications International Group Limited.

Contents

Quick Links

Help & Info

Log in

Staff number, email or mobile tel.

Password

Remember Me (Only tick if you are using your own personal device)

Forgot Your Password?

Don't have an account? Sign up

Change privacy settings